Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Open-market sale Director sold 1,200,000 shares at $105.47 ($126,564,000)
  2. 4/A Open-market sale Director sold 5,908 shares at $287.46 ($1,698,314)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Chief Executive Officer bought 4,000 shares at $117.88 ($471,520)
  16. 4 Open-market buy Chief Executive Officer bought 4,000 shares at $124.00 ($496,000)
  17. 4 Open-market buy Director bought 2,000 shares at an average $124.69 ($249,387)
  18. 4 Option exercise Director acquired 10,000 shares (option exercise)
  19. 4 Option exercise Director acquired 20,000 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 12 of 29 · 564 filings